Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 18

-Article 5

Name:	us-gaap_Assets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Note 8 - Segment Information (Details) - Operating Segment Asset Reconciliation (USD $) In Thousands, unless otherwise specified	Jun. 30, 2014	Mar. 31, 2014	Mar. 31, 2013
Total assets
Total assets	$ 110,284	$ 97,529	$ 97,529
Biological Indicators [Member]
Total assets
Total assets	26,458		22,771
Instruments [Member]
Total assets
Total assets	47,643		36,797
Continuous Monitoring [Member]
Total assets
Total assets	28,803		28,578
Corporate Segment [Member]
Total assets
Total assets	$ 7,380		$ 9,383